Phase II study of bi-weekly administration of paclitaxel and cisplatin in patients with advanced oesophageal cancer

In a phase I study we demonstrated the feasibility of a bi-weekly combination of paclitaxel 180 mg m(−2) with cisplatin 60 mg m(−2). In this study we further assessed toxicity and efficacy of this schedule in the treatment of advanced cancer of the oesophagus or the gastro-oesophageal junction. Pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Polee, M B, Eskens, F A L M, van der Burg, M E L, Splinter, T A W, Siersema, P D, Tilanus, H W, Verweij, J, Stoter, G, van der Gaast, A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2002
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375296/
https://www.ncbi.nlm.nih.gov/pubmed/11875723
http://dx.doi.org/10.1038/sj.bjc.6600166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375296/
https://www.ncbi.nlm.nih.gov/pubmed/11875723
http://dx.doi.org/10.1038/sj.bjc.6600166

Ejemplares similares